Talea Group S.p.A. (BIT:TALEA)
4.800
0.00 (0.00%)
At close: Jul 27, 2026
Talea Group Revenue
In the year 2024, Talea Group had annual revenue of 135.89M EUR with 1.09% growth. Talea Group had revenue of 53.04M in the half year ending December 31, 2024, a decrease of -16.56%.
Revenue
135.89M
Revenue Growth
+1.09%
P/S Ratio
0.31
Revenue / Employee
550.69K
Employees
240
Market Cap
40.74M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 135.89M | 1.46M | 1.09% |
| Dec 31, 2023 | 134.42M | 18.04M | 15.50% |
| Dec 31, 2022 | 116.39M | 33.87M | 41.05% |
| Dec 31, 2021 | 82.52M | 18.39M | 28.68% |
| Dec 31, 2020 | 64.13M | 22.62M | 54.51% |
| Dec 31, 2019 | 41.50M | 13.64M | 48.97% |
| Dec 31, 2018 | 27.86M | 12.96M | 87.00% |
| Dec 31, 2017 | 14.90M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| EL.En. | 595.51M |
| GPI S.p.A. | 546.18M |
| Svas Biosana | 141.56M |
| Farmacosmo | 56.13M |
| EuKedos | 52.91M |